Results Summary and Professional Abstract
Results of This Project
Medication Choices Based on Data, Not Fear
A narrative on this project, which highlights researchers' work into how patients with inflammatory bowel disease weigh treatment benefits and risks—and then are using that information to consider differences between two types of drugs.
Peer review of PCORI-funded research helps make sure the report presents complete, balanced, and useful information about the research. It also confirms that the research has followed PCORI’s Methodology Standards. During peer review, experts who were not members of the research team read a draft report of the research. These experts may include a scientist focused on the research topic, a specialist in research methods, a patient or caregiver, and a healthcare professional. Reviewers do not have conflicts of interest with the study.
The peer reviewers point out where the draft report may need revision. For example, they may suggest ways to improve how the research team analyzed its results or reported its conclusions. Learn more about PCORI’s peer-review process here.
In response to peer review, Lewis made changes including
- Adding sections to the Methods describing changes from the original study protocol for Aims 2 and 3 of the study
- Adding a supplemental table showing unweighted results of Aim 2 analyses, to show the associations before adjusting for confounding
- Adding a section to the Discussion to address remaining knowledge gaps and future directions
Conflict of Interest Disclosures
View the COI disclosure form.
Individuals with Multiple Chronic/co-morbid Conditions